The European Respiratory Diseases Forecasting Hub (RespiCast) is open for weekly submission of several respiratory disease indicators such as influenza-like-illness, acute respiratory infection and COVID-19.
This report provides an overview of the total number of cases of mpox (monkeypox) reported to ECDC and the WHO Regional Office for Europe through IHR/EWRS mechanisms .
On 11 – 15 December 2023, MediPIET Cohort 5, EPIET, EUPHEM and PAE fellows attended the annual Time Series Analysis (TSA) module hosted by Instituto Superiore di Sanita (ISS) in Rome, Italy.
Several viral and bacterial respiratory pathogens are expected to continue co-circulating at variable levels during the coming months, and contribute to increased morbidity and mortality during this period. This is typical of every winter season.
ECDC urges EU/EEA Member States to strengthen vaccination campaigns and prepare for the possible need to increase emergency department and ICU capacity, as well as to consider a number of public health measures to reduce the impact of respiratory pathogens circulating this winter, in latest epidemiological update.
On 12-13 December 2023, ECDC organised a simulation exercise on the serious cross-border threat posed by the spread of antimicrobial resistance, in collaboration with WHO.
To assess the level of preparedness of EU/EEA Member States to respond to zoonotic avian flu outbreaks, ECDC has carried out two surveys - one assessing the laboratory capacity for molecular diagnosis and characterisation of zoonotic influenza viruses, and the other focusing on measures applied to protect exposed people during outbreaks of highly pathogenic avian influenza.